Stay updated with breaking news from Cell Reports. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Immunotherapy is one of the pillars in the fight against cancer and aims to enable the body's own immune system to fight a tumor. A recent study now shows that removing certain enzymes that regulate epigenetic processes from the so-called dendritic cells of the immune system influences their development and thus improves anti-tumor immunity.
A recent collaborative research endeavor, published in Cell Reports Medicine, highlights a promising therapeutic avenue for amyotrophic lateral sclerosis (ALS). Led by researchers from Ben-Gurion University of the Negev in conjunction with counterparts from Germany, the U.S., and Canada, the study delves into the potential of augmenting macrophage migration inhibitory factor (MIF) protein levels as a novel approach to tackling ALS.
A new study by EPFL scientists shows that age-related decline in motor ability can be countered in fruit flies by enhancing the expression of the protein Trio, suggesting potential treatments for age-related movement decline.
Researchers conducted a Phase III trial to test the 100-year-old Bacillus Calmette-Gu rin (BCG) vaccine in people with type 1 diabetes during the COVID-19 pandemic.
A new study in Cell Reports suggests a way that mere mortals can potentially speed their recovery from a wide variety of injuries.